摘要
目的分析慢性阻塞性肺疾病急性加重(AECOPD)患者呼吸道病毒的感染情况及其危险因素。方法选取2016年1月至2017年6月本院呼吸内科收治的AECOPD患者118例,通过鼻咽拭子采集患者的呼吸道病毒标本,采用PCR法检测病毒,通过痰培养检测细菌/真菌,同时记录患者的病历资料等,采用Logistic回归分析病毒感染相关危险因素。结果痰培养阳性率为19.49%(23/118),PCR检测呼吸道病毒阳性率为41.53%(49/118),细菌和病毒混合感染发生率为7.63%(9/118);病毒阳性患者的住院时间为(12.54±2.12)d,显著长于病毒阴性患者的(8.37±1.51)d,差异有统计学意义(P<0.05);多因素逐步回归分析筛选出的AECOPD患者病毒感染的危险因素包括吸烟、糖尿病、呼吸衰竭以及既往1年内急性加重次数。结论 AECOPD患者呼吸道病毒感染率较高,尽早戒烟和控制血糖、改善肺功能、减少急性加重对降低AECOPD患者病毒感染风险具有重要意义。
Objective To investigate the distribution of respiratory viruses in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD),and analyze the risk factors of viral infection. Methods 118 patients with AECOPD from January 2016 to June 2017 in our hospital were enrolled into this study. Respiratory tract virus infection was detected by PCR and bacterial/fungal infection was detected by sputum culture. Using Logistic regression analysis was used to explore the related risk factors of viral infection. Results The positive rate of sputum culture was 19.49%(23/118). The positive rate of respiratory virus was 41.53%(49/118),and the incidence of mixed infection of bacteria and virus was 7.63%(9/118). The hospitalization time in virus positive patients was(12.54±2.12)d,significantly longer than that of virus negative patients[(8.37±1.51)d];the difference was statistically significant(P〈0.05). Stepwise regression analysis showed the risk factors of AECOPD patients with virus infection included smoking,diabetes,respiratory failure,acute exacerbation of the past one year. Conclusion AECOPD patients with a high rate of virus infection,and quit smoking,control blood glucose,improve lung function and reduce acute exacerbation of AECOPD patients could help to lower the viral infection risk.
作者
蓝英萍
蒋玲
宁小平
LAN Ying-ping;JIANG Ling;NING Xiao-ping(Department of Respiratory, the Central Hospital of Bao'an District, Shenzhen, Guangdong 518000, China)
出处
《热带医学杂志》
CAS
2018年第5期681-684,688,共5页
Journal of Tropical Medicine
关键词
慢性阻塞性肺疾病急性加重
呼吸道病毒
危险因素
Acute exacerbation chronic obstructive pulmonary disease
Respiratory virus
Risk factors